24l~Topical Steroids c Anti Fungal

CPR : JULY-OCTOBER 2010

© C MARC (India) Private Limited– This document should not be copied or distributed without C MARC authorization

July – October 2010



0

20

40

60

80

100

120

140

160

180

BA

SE

M-J

'08

J-O

'08

N'0

8-F

'09

M-J

'09

J-O

'09

N'0

9-F

'10

M-J

'10

J-O

'10

TOPICAL STEROID CANTIFUNGALS

CANDID-B CREAM[Glenmark-Ph ]

EUMOSONE-M CREAM[GSK - DERMA ]

ZOLE F OINT [RBXY-MAXXIM ]

CANESTEN-S CREAM[BAYER HC ]

CANDID-B LOTION[Glenmark-Ph ]

Overall / All Speciality

TOPICAL St. Comb.with ANTIFUNGALS. Rx Response Trend Base: Jan-Dec 2005, Four Monthly Avg.=100



TOPICAL STEROID C ANTIFUNGALS

CPR OVER ALL Absolute Rx Response Trend Four Monthly

MOLECULE / BRAND MAR-JUN'08

JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10

TOPICAL STEROID C ANTIFUNGALS4154 4608 4470 4136 4193 4125 3889 4227

CANDID-B CREAM [Glenmark-Ph ] 1098 1258 1166 1069 1216 1131 1050 1230

EUMOSONE-M CREAM [GSK - DERMA ]425 408 460 452 356 399 451 413

ZOLE F OINT [RBXY-MAXXIM ] 397 513 452 380 465 458 371 379

CANESTEN-S CREAM [BAYER HC ]315 360 318 327 289 331 263 310

KETO-B CREAM [MED MANOR ] 161 212 227 223 258 275 254 291

CANDID-B LOTION [Glenmark-Ph ] 196 196 208 180 201 190 177 191

BETNOVATE-C CREAM [GSK - DERMA ]196 196 234 209 151 180 166 139

TENOVATE-M CREAM [GSK - DERMA ]181 162 133 172 127 146 157 117

TRIBEN-B CREAM [JENBURKT PH ] 78 107 89 68 63 95 83 97

CLOTRIN-B CREAM [NULIFE Ph. ] 70 83 78 77 83 63 78 89

LOBATE-M CREAM / SKIN CREAM [PHL-DERMA ]66 96 91 80 60 76 73 80

ZOLE F LOTION [RBXY-MAXXIM ]87 66 69 56 69 82 43 67



C P R 116 0.42 0.15

DERMAT 22 3.90 1.13GYNAE 63 0.73 0.25PAEDIA 82 0.47 0.15

GEN PHY 96 0.41 0.13UROLOGIST 81 0.32 0.14ONCO 99 0.31 0.10

GEN SURG 98 0.27 0.09CONS PHY 106 0.24 0.07

FOR EACH SPECIALITY 100 Rxer x 200 Rx=20,000 RxRANK: indicates standing of this category in respective speciality

Rx REACH by SPECIALITYTOPICAL STEROID C ANTIFUNGALS

Period: JUL- OCT 2010

Speciality

RA

NK

Rx%% to Total

Drug




Specialist: DERMAT Absolute Rx Response Trend Four Monthly


JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10







SEBIFIN PLUS CREAM [RBXY-PRIMALA] 10 36 45 50 40


KANSEL-B LOTION [PALSONS ] 19 23 17 18 22 28 26 35

PROPYZOLE OINT [H & H Pharma] 34 45 38 19 16 16 14 26

LOBATE-M CREAM / SKIN CREAM [PHL-DERMA ]19 18 20 22 16 13 27 25

MOMOZ-T CREAM [UNICHEM-UNIK]10 11 9 9 18 15 15 25

MOMSTAR T OINT [MANKIND PH ] 2 2 4 9 7 7 23




Specialist: GYNAE Absolute Rx Response Trend Four Monthly


JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10





TRIBEN-B CREAM [JENBURKT PH ] 2 6 4 4 6 5 2 8

CLOTRIN-B CREAM [NULIFE Ph. ] 9 7 6 4 8 7 7 8


SURFAZ B CREAM / OINT [FRANCO (I) ] 4






Specialist: PAEDIA Absolute Rx Response Trend Four Monthly


JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10






ZOLE F LOTION [RBXY-MAXXIM ] 3 4 2 3 2 2 1 3


LOZEE-M CREAM [APEX Lab ] 2 3 5 3 3 5 4 2

TENOVATE-M CREAM [GSK - DERMA ] 1 2 1 1 1




Specialist: GP Absolute Rx Response Trend Four Monthly


JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10





CANESTEN-S CREAM [BAYER HC ] 9 10 8 8 7 8 7 7








Specialist: CONS. PHY. Absolute Rx Response Trend Four Monthly


JULY-OCT'08

NOV-FEB'09

MAR-JUN'09

JULY-OCT'09

NOV-FEB'10

MAR-JUN'10

JULY-OCT'10





CANESTEN-S CREAM [BAYER HC ] 2 3 6 6 5 4 4 4



SURFAZ B CREAM / OINT [FRANCO (I) ] 1 2



40

97

12

54

23

1 13

1 1 13 3

13

1

15

97

32

19

1 0 1 0 0 1 02 1 0 1

40

0

5

10

15

20

25

30

35

40

45

G P

GYNAE

PAED

IA

CONS

SURGEO

N

CARDIO

DERM

ATE N T

PSYCH

IA

GASTRO

ORTHO

NEU

RO

NEP

HRO

URO

DENTI

ST

CHES

T

ONCO

OPHTH

AL

DIABE

TO

CPR : Rxer%


: Rx ( %) Distribution Across Speciality




TOPICAL STEROID C ANTIFUNGALSRxER BASE & PERCAPITA

CAT/ MOL/ BRANDRxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

TOPICAL STEROID C ANTIFUNGALS 21 2.0 21 2.1 74 5.0 75 5.2 31 2.4 28 2.6 29 1.8 29 1.6

TOP.ST.COMB.WITH ANTIFUNGAL 21 2.0 21 2.1 74 5.0 75 5.2 31 2.4 28 2.6 29 1.8 29 1.6EUMOSONE-M CREAM [GSK - DERMA ]2 1.7 2 1.7 20 2.6 22 2.9 1 1.2 1 1.6 12 1.7 13 1.5CANDID-B CREAM [Glenmark-Ph ] 7 1.7 7 1.8 20 2.6 20 2.6 16 2.4 14 2.4 8 1.4 8 1.4CANDID-B LOTION [Glenmark-Ph ] 1 1.4 1 1.4 13 2.0 14 1.9 1 1.1 1 1.3 3 1.3 2 1.2CANESTEN-S CREAM [BAYER HC ] 2 1.7 2 1.8 9 2.4 10 2.6 3 1.5 3 2.0 0.7 1.0 0.8 2.2KETO-B CREAM [MED MANOR ] 2 1.6 2 1.9 6 2.1 8 2.2 3 2.2 2 2.5 1 1.1 0.9 1.3TENOVATE-M CREAM [GSK - DERMA ]0.8 1.5 0.7 1.6 8 2.4 8 2.7 0.3 1.0 0.3 1.7 0.4 2.2 0.4 1.3SEBIFIN PLUS CREAM [RBXY-PRIMALA]0.2 2.5 0.3 2.1 7 2.7 6 3.2 0.1 1.0 0.1 1.0LOBATE-M CREAM / SKIN CREAM [PHL-DERMA ]0.5 1.4 0.5 1.6 5 1.6 5 2.6 0.2 1.6 0.5 1.1 0.3 1.0 0.3 1.0PROPYZOLE OINT [H & H Pharma] 0.2 1.7 0.2 2.3 4 2.1 5 2.7 0.1 1.0KANSEL-B GEL [PALSONS ] 0.2 2.3 0.2 1.7 5 3.0 5 2.3 0.1 1.0KANSEL-B LOTION [PALSONS ] 0.2 2.5 0.2 3.1 4 3.1 4 3.9MOMOZ-T CREAM [UNICHEM-UNIK] 0.1 2.7 0.1 2.5 3 2.9 4 3.2TRIBEN-B LOTION [JENBURKT PH ] 0.2 1.7 0.2 1.4 4 2.2 4 2.1 0.1 3.1 0.2 1.0BETNOVATE-C CREAM [GSK - DERMA ]1 1.3 1 1.2 2 1.5 3 1.4 1 1.2 2 1.1 0.4 1.5 0.6 1.2MOMSTAR T OINT [MANKIND PH ] 0.1 2.7 0.2 2.3 2 2.6 3 3.3TRIBEN-B CREAM [JENBURKT PH ] 0.3 1.9 0.5 2.0 4 2.9 3 2.7 2 1.8 2 2.3 0.1 1.0 0.2 2.2CLOTRIN-B CREAM [NULIFE Ph. ] 0.3 2.6 0.4 2.3 1 3.7 2 2.9 1 3.3 1 3.0 0.1 1.0 0.1 2.2BETAMIL-M CREAM [MERCK-ETH BC]0.1 1.8 0.1 1.7 2 2.3 2 2.2CLOVATE CREAM [DERMOCARE ] 1.5 0.1 1.4 2 1.5 2 1.6CLOP-M CREAM [Zydus-LivaHc] 0.2 1.5 0.2 1.6 2 2.2 2 2.0 0.3 1.7 0.2 2.0 0.3 1.8 0.1 1.0ZOLE F OINT [RBXY-MAXXIM ] 3 1.6 3 1.4 2 2.8 2 1.2 2 2.1 2 1.5 3 1.4 4 1.2SURFAZ B CREAM / OINT [FRANCO (I) ] 0.5 1.4 2 2.0 0.9 2.1 0.2 1.0EXEL-M CREAM [RBXY-CROSL 1] 0.1 1.2 0.1 2.4 1 1.2 1 3.4FLUCORT C CREAM [Glen-GRACWEL]0.5 1.4 0.4 1.2 2 1.9 1 1.7 0.5 1.2 0.2 3.6LOZEE-M CREAM [APEX Lab ] 0.1 1.8 0.1 1.3 2 2.2 1 1.2 0.9 1.8 0.8 1.5ZOLE F LOTION [RBXY-MAXXIM ] 0.5 1.4 0.6 1.1 1 1.4 1 1.0 0.4 1.5 0.6 1.2 0.7 1.4 0.9 1.2BECLOCID-G CREAM [CHEMO DRUGS ]0.1 4.6 0.1 1.2 0.2 40.4 0.6 1.7 0.1 1.0 0.3 1.0FLUCORT MZ OINT [Glen-MILIEUS] 0.2 1.4 0.1 1.7 0.7 1.6 0.6 5.6ZINCODERM-M CREAM [APEX Lab ]0.1 4.9 0.2 1.5 0.8 4.8 0.6 8.7 0.1 1.1 0.1 1.0HALOBET MZ OINT [AJNTA-ZILION] 1.0 0.1 1.5 0.3 1.0 0.4 1.0BETNOVATE-M SKIN CREAM [GSK - DERMA ]0.2 1.1 0.2 1.2 0.3 1.6 0.2 1.0 0.2 1.1 0.1 1.0 0.2 2.5EXEL-M OINT [RBXY-CROSL 1] 0.1 2.5 0.1 1.9 0.2 3.0 0.2 1.6 0.2 2.7CLOCIP-B CREAM [CIPLA-GENERC] 0.2 2.3 0.1 1.7CONZOLE-B CREAM [PARK-ROBINS ]0.1 1.5 0.1 2.5 0.2 2.2 0.2 3.5

GYNAEJUL-OCT̀ 09 JUL-OCT̀ 10

PAEDIAJUL-OCT̀ 09 JUL-OCT̀ 10

C P RJUL-OCT̀ 09 JUL-OCT̀ 10

DERMATJUL-OCT̀ 09 JUL-OCT̀ 10



TOPICAL STEROID C ANTIFUNGALSRxER BASE & PERCAPITA

CAT/ MOL/ BRANDRxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

Rxer Base

Per Capita

TOPICAL STEROID C ANTIFUNGALS 24 1.7 24 1.7 11 1.7 17 1.9 6 1.7 17 1.8 16 1.7 14 1.7

TOP.ST.COMB.WITH ANTIFUNGAL 24 1.7 24 1.7 11 1.7 17 1.9 6 1.7 17 1.8 16 1.7 14 1.7EUMOSONE-M CREAM [GSK - DERMA ]1 1.3 1 1.3 1 1.7 1 1.7CANDID-B CREAM [Glenmark-Ph ] 7 1.5 7 1.6 4 2.1 9 2.2 4 1.8 10 2.1 4 1.3 5 1.6CANDID-B LOTION [Glenmark-Ph ] 2 1.3 2 1.2 0.6 1.3 1 1.0CANESTEN-S CREAM [BAYER HC ] 2 1.6 2 1.6 0.5 5.1 0.8 1.2 1 1.7 1 1.9KETO-B CREAM [MED MANOR ] 2 1.4 2 1.7 0.6 1.3 0.8 1.4TENOVATE-M CREAM [GSK - DERMA ]0.9 1.1 0.7 1.3 0.7 2.1 1 3.1 0.8 1.5 0.6 1.1SEBIFIN PLUS CREAM [RBXY-PRIMALA] 0.2 1.0LOBATE-M CREAM / SKIN CREAM [PHL-DERMA ]0.7 1.3 0.6 1.3 0.1 1.0 0.3 1.1PROPYZOLE OINT [H & H Pharma] 0.2 1.5 0.1 1.5KANSEL-B GEL [PALSONS ] 0.1 1.3 0.2 1.0 0.1 1.1 0.2 1.5KANSEL-B LOTION [PALSONS ] 0.1 1.1 0.2 2.1 0.4 2.4 0.2 2.0MOMOZ-T CREAM [UNICHEM-UNIK] 0.1 3.0 0.1 1.1TRIBEN-B LOTION [JENBURKT PH ] 0.1 1.4 0.2 1.0BETNOVATE-C CREAM [GSK - DERMA ]2 1.2 1 1.3 1 1.1 2 1.2 1 1.1 2 1.4 1 1.1MOMSTAR T OINT [MANKIND PH ] 0.1 1.5 0.1 2.0 0.2 2.1TRIBEN-B CREAM [JENBURKT PH ] 0.2 1.2 0.5 1.5CLOTRIN-B CREAM [NULIFE Ph. ] 0.4 2.2 0.4 1.8 0.1 1.0 0.1 1.0BETAMIL-M CREAM [MERCK-ETH BC] 0.1 1.0CLOVATE CREAM [DERMOCARE ] 0.1 1.0CLOP-M CREAM [Zydus-LivaHc] 0.2 1.0 0.2 1.6ZOLE F OINT [RBXY-MAXXIM ] 4 1.6 4 1.4 3 1.2 4 1.9 0.8 1.0 5 1.1 3 1.2 2 1.3SURFAZ B CREAM / OINT [FRANCO (I) ] 0.6 1.2 0.7 1.2EXEL-M CREAM [RBXY-CROSL 1] 1.0 0.1 1.0FLUCORT C CREAM [Glen-GRACWEL]0.6 1.3 0.5 1.0 0.9 1.0 0.3 1.0 0.3 1.0LOZEE-M CREAM [APEX Lab ] 0.1 1.0ZOLE F LOTION [RBXY-MAXXIM ] 0.6 1.4 0.7 1.1 0.4 1.1 0.7 1.1BECLOCID-G CREAM [CHEMO DRUGS ]0.1 2.5 0.1 1.0FLUCORT MZ OINT [Glen-MILIEUS] 0.2 1.5 0.2 1.0 0.2 1.0 0.1 1.1ZINCODERM-M CREAM [APEX Lab ]0.1 1.0 0.3 1.1 0.2 14.0 0.1 1.0HALOBET MZ OINT [AJNTA-ZILION] 1.3 0.2 1.8BETNOVATE-M SKIN CREAM [GSK - DERMA ]0.2 1.0 0.3 1.0EXEL-M OINT [RBXY-CROSL 1] 0.1 2.6 0.1 1.0 0.1 3.2 0.1 2.4CLOCIP-B CREAM [CIPLA-GENERC] 0.2 2.7 0.2 2.0 0.3 2.0 0.2 1.5CONZOLE-B CREAM [PARK-ROBINS ]0.1 1.0 0.1 2.0

ONCOJUL-OCT̀ 09 JUL-OCT̀ 10

CONS PHYJUL-OCT̀ 09 JUL-OCT̀ 10

GEN PHYJUL-OCT̀ 09 JUL-OCT̀ 10

UROLOGISTJUL-OCT̀ 09 JUL-OCT̀ 10



TOPICAL STEROID C ANTIFUNGALSRx RS BY MAJOR PD / PC [ 1 ] C P R (OVERALL)

PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

ZO

LE

F O

INT

CA

NE

ST

EN

-S

CR

EA

M

KE

TO

-B C

RE

AM

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

CL

OT

RIN

-B C

RE

AM

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

ZO

LE

F L

OT

ION

SU

RF

AZ

B C

RE

AM

/ O

INT

SE

BIF

IN P

LU

S

CR

EA

M

KA

NS

EL

-B L

OT

ION

Rx TOTAL : 1227 405 375 307 290 195 137 117 100 89 80 69 65 59 52TINEA CRUS / CRURIS 4.4 3.3 1.2 5.6 7.8 4.1 2.1 1.5 2.6 11.0 11.2 1.3 5.8 9.2 6.8 1.9

100 21 3 11 13 6 2 1 2 6 5 1 2 3 2 1TINEA CORPORIS 3.0 1.6 2.5 2.9 4.9 2.8 5.1 4.3 13.0 1.1 6.3 6.2 10.2 1.9

100 16 8 9 12 6 8 4 10 1 4 3 5 1TINEA INFECTION 1.5 0.9 2.0 1.6 1.0 1.4 0.5 3.4 6.0 2.5 2.9 3.4

100 17 13 9 5 6 2 6 9 3 3 3T V (TINEA VERSICULOSIS) 1.0 0.3 1.0 0.3 2.9 1.0 1.0 0.9 1.0 3.8 6.2 3.4

100 9 9 2 21 7 5 2 2 7 9 5TINEA PEDIS 0.7 0.1 0.7 1.0 0.5 4.3 2.0 1.1 2.5 1.7

100 4 7 11 4 18 7 4 7 4TINEASIS 0.3 1.3 1.4 0.5 0.9 2.0

100 29 29 7 7 14TINEA CAPITIS 0.3 0.3 1.0 1.5 2.9

100 9 27 18 18FUNGAL INFECTION 5.7 6.4 1.7 8.8 3.3 6.2 7.7 3.6 5.1 7.0 3.4 4.3 6.2 1.7 11.5

100 33 3 14 4 8 6 2 3 3 1 1 2 3DERMATITIS 3.9 2.4 5.2 1.9 2.6 2.8 4.1 10.9 1.7 6.0 6.7 6.3 1.4 3.1 10.2 5.8

100 18 13 4 5 5 5 9 1 4 4 3 1 1 4 2DERMAT (CONTACT) 0.4 0.2 0.7 0.3 2.2 1.7 1.0

100 12 18 6 18 12 6ATOPIC DERMATITIS 0.3 0.5 0.5 0.9 1.3

100 18 18 9 9VAGINITIS 4.4 6.8 0.7 3.2 7.5 4.5 2.1 0.7 0.9 5.0 12.4 2.5 2.9 6.2

100 45 2 7 12 7 2 1 1 3 6 1 1 2U T I 4.4 6.0 2.0 6.4 9.4 1.4 6.2 8.0 0.9 4.0 6.2

100 40 4 13 16 2 7 6 1 2 2




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

ZO

LE

F O

INT

CA

NE

ST

EN

-S

CR

EA

M

KE

TO

-B C

RE

AM

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

CL

OT

RIN

-B C

RE

AM

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

ZO

LE

F L

OT

ION

SU

RF

AZ

B C

RE

AM

/ O

INT

SE

BIF

IN P

LU

S

CR

EA

M

KA

NS

EL

-B L

OT

ION

Rx TOTAL : 1227 405 375 307 290 195 137 117 100 89 80 69 65 59 52G I DISORDER 4.0 3.3 10.4 4.3 2.3 2.4 2.6 3.6 3.4 1.0 2.5 7.2 4.6 10.2

100 24 25 10 4 4 3 3 2 1 1 3 2 4PRURITUS 2.8 4.9 5.9 3.3 4.1 0.5 1.5

100 51 19 9 10 1 2RASH 2.8 2.4 5.9 4.3 0.7 1.4 1.5 8.8 1.7 1.0 1.3 4.3

100 26 21 14 2 3 3 10 2 1 1 3PREGNANCY 2.7 5.1 0.7 0.8 2.9 2.4 1.0 3.6 0.9 2.0 1.1 3.8 1.4 3.1

100 56 3 3 8 6 2 4 1 2 1 3 1 2DIABETES MELLITUS 2.5 3.7 0.5 3.2 1.3 3.4 1.5 0.7 5.1 1.0 1.5 1.7 1.9

100 43 2 11 4 9 3 1 6 1 1 1 1ECZEMA 2.2 0.8 1.5 2.1 1.6 0.3 2.1 5.8 4.3 5.0 3.8 2.9 3.4 7.7

100 11 7 9 5 1 4 9 5 5 3 2 2 4SEBORRHOEA DERMATITIS 1.9 0.4 6.4 0.5 0.7 0.7 5.1 0.7 1.7 2.9 5.1 9.6

100 6 33 3 3 3 13 1 3 3 4 6U R T I 1.7 1.8 3.7 1.3 0.3 1.5 2.2 5.8

100 31 21 7 1 4 4 6CANDIDIASIS 1.4 2.2 0.2 1.3 3.1 3.0 1.1 4.6 6.8

100 46 2 7 15 5 2 5 7PITYRIASIS 1.3 0.7 4.2 0.3 0.3 1.5 1.5 4.3 1.4 5.1 3.8

100 16 30 2 2 5 4 9 2 5 4HYPERTENSION 1.2 1.5 0.5 1.9 0.3 1.0 2.6 1.5 2.9 1.5 1.7

100 37 4 14 2 6 10 4 4 2 2LEUKORRHEA 1.2 2.0 1.3 3.3 0.3 5.1 3.0 1.5

100 48 10 19 2 14 6 2ACNE VULGARIS / COMEDOMES1.0 1.2 2.0 0.3 1.4 1.5 0.7 1.7 5.8

100 34 18 2 9 7 2 2 7




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

ZO

LE

F O

INT

CA

NE

ST

EN

-S

CR

EA

M

KE

TO

-B C

RE

AM

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

CL

OT

RIN

-B C

RE

AM

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

ZO

LE

F L

OT

ION

SU

RF

AZ

B C

RE

AM

/ O

INT

SE

BIF

IN P

LU

S

CR

EA

M

KA

NS

EL

-B L

OT

ION

Rx TOTAL : 1227 405 375 307 290 195 137 117 100 89 80 69 65 59 52HYPOPIGMENTER 0.8 0.3 2.2 0.3 0.3 0.7 1.5 1.5 3.4

100 11 26 3 3 6 9 6 6BALANITIS 0.7 0.7 0.5 0.8 0.3 1.4 0.5 1.1 1.3 1.7

100 30 7 10 3 13 3 3 3 3MENSTRUAL DISORDER 0.7 0.7 1.6 1.6 4.4 1.4 1.5

100 29 21 18 21 4 4ALLERGIC RHINITIS 0.6 0.4 0.2 1.1 0.7 1.0 1.0 0.7 3.8 1.4

100 20 4 16 8 12 8 4 12 4PSORIASIS 0.5 0.1 1.0 0.3 0.5 3.4 1.0 1.3

100 5 18 5 5 18 5 5URTICARIA 0.5 0.4 0.2 0.8 0.7 0.5 0.9 1.7

100 24 5 14 10 5 5 5SCABIES 0.5 0.7 0.5 1.5

100 43 10 5HYPOTHYROIDISM 0.5 0.6 0.2 0.5 0.3 1.5 2.2

100 35 5 10 5 15 15VITILIGO 0.4 0.5 0.5 2.6 1.1

100 11 6 17 6GIDDINESS 0.4 0.8 0.2 0.8 0.7 3.1

100 56 6 17 11 11LICHEN SIMPLEX 0.4 0.2 1.0 0.7 0.9 2.5 1.5

100 11 22 11 6 11 6L S C S (LOWER SEGMENT CAESARIAN SECTION0.4 0.5 1.0 1.3

100 33 22 22WORM INFESTATION 0.4 0.3 1.6 0.3 1.0 0.7

100 24 35 6 12 6




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

ZO

LE

F O

INT

CA

NE

ST

EN

-S

CR

EA

M

KE

TO

-B C

RE

AM

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

CL

OT

RIN

-B C

RE

AM

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

ZO

LE

F L

OT

ION

SU

RF

AZ

B C

RE

AM

/ O

INT

SE

BIF

IN P

LU

S

CR

EA

M

KA

NS

EL

-B L

OT

ION

Rx TOTAL : 1227 405 375 307 290 195 137 117 100 89 80 69 65 59 52OTITIS MEDIA 0.4 0.5 0.7 0.3 0.7 4.3 1.7

100 40 20 7 7 20 7LESION 0.4 0.2 0.3 0.7 0.7 1.7 2.2

100 20 7 13 13 13 13ABSCESS 0.3 0.1 0.5 0.5 0.5 1.5 2.6 1.0

100 8 17 17 8 17 25 8ITCHING ALL OVER BODY 9.8 12.6 4.0 12.8 12.4 8.3 5.6 13.1 2.6 13.0 13.5 3.8 10.1 24.6 5.1 3.8

100 37 4 12 9 6 3 4 1 3 3 1 2 4 1 1PAIN 3.3 3.6 0.5 3.7 2.9 1.7 1.5 8.0 6.8 3.0 1.1 3.8 12.3

100 32 1 10 7 4 2 8 6 2 1 2 6FEVER 3.0 3.7 4.9 1.6 2.6 3.4 1.5 2.9 6.0 2.2 2.9 4.6

100 36 16 5 6 8 2 3 6 2 2 2G WEAK WITH ANAEMIA 2.6 4.3 1.2 4.0 1.6 2.4 3.1 0.9 4.0 2.5 1.5

100 48 5 14 5 6 5 1 4 2 1COUGH/COLD 2.0 1.2 6.7 1.6 1.6 2.4 2.1 3.6 0.9 6.3 1.4 1.7

100 18 32 7 6 8 5 6 1 6 1 1PAIN ABDOMEN 1.6 2.0 2.7 2.4 2.9 1.4 0.5 0.7 1.1 1.7

100 35 16 13 13 6 1 1 1 1BOIL ALL OVER BODY 1.4 1.4 0.5 2.4 1.0 2.1 1.5 2.9 2.6 1.0 4.3 3.1

100 28 3 15 5 10 5 7 5 2 5 3INFECTION 1.4 1.3 0.7 1.1 0.3 2.8 1.5 1.3 6.2 5.8

100 26 5 7 2 13 5 2 7 5WHITE DISCHARGE 1.3 2.0 1.6 2.6 3.1 0.7 1.0 1.1

100 44 11 15 17 2 2 2




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

ZO

LE

F O

INT

CA

NE

ST

EN

-S

CR

EA

M

KE

TO

-B C

RE

AM

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

CL

OT

RIN

-B C

RE

AM

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

ZO

LE

F L

OT

ION

SU

RF

AZ

B C

RE

AM

/ O

INT

SE

BIF

IN P

LU

S

CR

EA

M

KA

NS

EL

-B L

OT

ION

Rx TOTAL : 1227 405 375 307 290 195 137 117 100 89 80 69 65 59 52SOFT ABDOMEN 1.1 2.4 1.0 0.5 1.0 0.5 2.2 1.4

100 64 9 4 7 2 4 2SKIN INFECTION 0.9 0.3 0.5 1.1 0.7 1.0 0.5 1.5 6.0 1.0 1.1 3.1 5.8

100 11 5 11 5 8 3 5 18 3 3 5 8BURNING SENSATION ALL BODY0.8 1.0 1.3 1.3 1.0 0.9 3.8 1.5

100 34 14 11 9 3 9 3ALLERGY 0.7 0.5 0.7 1.7 3.6 1.7 1.1 3.8

100 21 11 18 18 7 4 11DANDRUFF 0.6 0.5 6.2 1.4 11.5

100 8 46 4 23SWELLING 0.6 0.4 0.5 0.7 1.4 2.2 4.0 1.3

100 21 8 8 17 13 17 4ALOPECIA 0.5 0.3 0.2 0.5 4.1 0.7 1.7 3.8

100 18 5 9 36 5 5 9VOMITING 0.5 0.8 1.0 0.8 0.3 0.5 1.3 1.7

100 48 19 14 5 5 5 5TENDERNESS 0.5 0.7 0.5 0.5 1.3 3.1

100 45 10 5 5 10INSECT BITE 0.3 0.1 1.2 0.7 1.5 1.5

100 7 36 14 21 14WHITE PATCH 0.3 0.1 1.0 3.6

100 8 33 42REDNESS OF EYE 0.3 0.3 1.0 0.5 1.4

100 36 36 9 9




PD/PC

CA

TE

GO

RY

FL

UC

OR

T C

C

RE

AM

MO

MS

TA

R T

OIN

T

PR

OP

YZ

OL

E O

INT

KA

NS

EL

-B G

EL

TR

IBE

N-B

LO

TIO

N

CO

NZ

OL

E-M

L

OT

ION

ST

AT

UM

-B C

RE

AM

MO

MO

Z-T

CR

EA

M

CL

OP

-M C

RE

AM

LU

PID

ER

M-M

C

RE

AM

ZIN

CO

DE

RM

-M

CR

EA

M

BE

TN

OV

AT

E-M

S

KIN

CR

EA

M

CL

OC

IP-B

CR

EA

M

FU

NG

ID N

.C. O

INT

FL

UC

OR

T M

Z O

INT

Rx TOTAL : 44 37 37 32 30 30 28 27 25 24 23 22 21 18 17TINEA CRUS / CRURIS 4.4 2.3 16.2 5.4 3.1 10.0 7.4 20.8 21.7 9.1 9.5 23.5

100 1 3 1 1 2 1 3 3 1 1 2TINEA CORPORIS 3.0 8.1 3.1 7.4 4.2 21.7 5.9

100 2 1 2 1 4 1TINEA INFECTION 1.5 8.1 3.1 7.4 29.2 18.2

100 5 2 3 11 6T V (TINEA VERSICULOSIS) 1.0 3.3 4.2

100 2 2TINEA PEDIS 0.7 6.8 3.7 11.8

100 11 4 7TINEASIS 0.3 2.3

100 7TINEA CAPITIS 0.3

100FUNGAL INFECTION 5.7 6.8 10.8 5.4 6.7 17.9 11.1 12.0 9.1 4.8 17.6

100 1 2 1 1 2 1 1 1 1DERMATITIS 3.9 6.8 5.4 8.1 3.1 10.0 6.7 14.8 12.5 34.8 17.6

100 2 1 2 1 2 1 2 2 5 2DERMAT (CONTACT) 0.4 2.7 4.0 4.2

100 6 6 6ATOPIC DERMATITIS 0.3 4.5 5.9

100 9 9VAGINITIS 4.4 6.7 10.7 11.1

100 1 2 1U T I 4.4 4.0 8.3

100 1 1




PD/PC

CA

TE

GO

RY

FL

UC

OR

T C

C

RE

AM

MO

MS

TA

R T

OIN

T

PR

OP

YZ

OL

E O

INT

KA

NS

EL

-B G

EL

TR

IBE

N-B

LO

TIO

N

CO

NZ

OL

E-M

L

OT

ION

ST

AT

UM

-B C

RE

AM

MO

MO

Z-T

CR

EA

M

CL

OP

-M C

RE

AM

LU

PID

ER

M-M

C

RE

AM

ZIN

CO

DE

RM

-M

CR

EA

M

BE

TN

OV

AT

E-M

S

KIN

CR

EA

M

CL

OC

IP-B

CR

EA

M

FU

NG

ID N

.C. O

INT

FL

UC

OR

T M

Z O

INT

Rx TOTAL : 44 37 37 32 30 30 28 27 25 24 23 22 21 18 17G I DISORDER 4.0 9.1 8.1 16.0 4.2 34.8 9.5

100 2 2 2 1 5 1PRURITUS 2.8 4.5 2.7 10.0 5.6

100 2 1 3 1RASH 2.8 10.8 3.3 10.0 7.1 3.7 24.0 4.5

100 3 1 3 2 1 5 1PREGNANCY 2.7 3.1 8.0 22.2

100 1 2 4DIABETES MELLITUS 2.5 11.4 3.3 3.3 10.7 13.6 17.6

100 5 1 1 3 3 3ECZEMA 2.2 2.7 10.8 21.9 4.2 8.7

100 1 4 8 1 2SEBORRHOEA DERMATITIS 1.9 3.1 16.7 11.1 8.0

100 1 6 4 3U R T I 1.7 6.8 3.3 25.0 4.5

100 4 1 9 1CANDIDIASIS 1.4 6.3 5.9

100 3 2PITYRIASIS 1.3 13.3 3.7 5.9

100 7 2 2HYPERTENSION 1.2 9.1 3.6

100 8 2LEUKORRHEA 1.2

100ACNE VULGARIS / COMEDOMES1.0 2.7 3.3 3.7

100 2 2 2




PD/PC

CA

TE

GO

RY

FL

UC

OR

T C

C

RE

AM

MO

MS

TA

R T

OIN

T

PR

OP

YZ

OL

E O

INT

KA

NS

EL

-B G

EL

TR

IBE

N-B

LO

TIO

N

CO

NZ

OL

E-M

L

OT

ION

ST

AT

UM

-B C

RE

AM

MO

MO

Z-T

CR

EA

M

CL

OP

-M C

RE

AM

LU

PID

ER

M-M

C

RE

AM

ZIN

CO

DE

RM

-M

CR

EA

M

BE

TN

OV

AT

E-M

S

KIN

CR

EA

M

CL

OC

IP-B

CR

EA

M

FU

NG

ID N

.C. O

INT

FL

UC

OR

T M

Z O

INT

Rx TOTAL : 44 37 37 32 30 30 28 27 25 24 23 22 21 18 17HYPOPIGMENTER 0.8 2.7 22.7 14.3

100 3 14 9BALANITIS 0.7 3.3 9.1 9.5

100 3 7 7MENSTRUAL DISORDER 0.7 11.1

100 7ALLERGIC RHINITIS 0.6 2.3 9.5

100 4 8PSORIASIS 0.5 2.7 3.1 3.3 4.0

100 5 5 5 5URTICARIA 0.5 2.7 3.7

100 5 5SCABIES 0.5 4.5 2.7

100 10 5HYPOTHYROIDISM 0.5 2.3

100 5VITILIGO 0.4 2.7 3.6 3.7

100 6 6 6GIDDINESS 0.4

100LICHEN SIMPLEX 0.4 3.1 3.7

100 6 6L S C S (LOWER SEGMENT CAESARIAN SECTION0.4 5.6

100 6WORM INFESTATION 0.4 8.7

100 12




PD/PC

CA

TE

GO

RY

FL

UC

OR

T C

C

RE

AM

MO

MS

TA

R T

OIN

T

PR

OP

YZ

OL

E O

INT

KA

NS

EL

-B G

EL

TR

IBE

N-B

LO

TIO

N

CO

NZ

OL

E-M

L

OT

ION

ST

AT

UM

-B C

RE

AM

MO

MO

Z-T

CR

EA

M

CL

OP

-M C

RE

AM

LU

PID

ER

M-M

C

RE

AM

ZIN

CO

DE

RM

-M

CR

EA

M

BE

TN

OV

AT

E-M

S

KIN

CR

EA

M

CL

OC

IP-B

CR

EA

M

FU

NG

ID N

.C. O

INT

FL

UC

OR

T M

Z O

INT

Rx TOTAL : 44 37 37 32 30 30 28 27 25 24 23 22 21 18 17OTITIS MEDIA 0.4

100LESION 0.4 14.3

100 20ABSCESS 0.3

100ITCHING ALL OVER BODY 9.8 5.4 2.7 9.4 6.7 13.3 7.1 20.0 4.2 17.4 36.4 5.6

100 1 1 1 1 1 1 1 2PAIN 3.3 2.3 2.7 6.7 6.7 4.0 4.2 9.1 29.4

100 1 1 1 1 1 1 1 4FEVER 3.0 2.3 8.1 6.7 3.3 4.0 14.3

100 1 2 2 1 1 2G WEAK WITH ANAEMIA 2.6 16.2 16.0 8.7

100 5 4 2COUGH/COLD 2.0 8.1 3.3 3.6

100 4 1 1PAIN ABDOMEN 1.6 4.5 8.0 5.6

100 3 3 1BOIL ALL OVER BODY 1.4 8.7 9.5

100 3 3INFECTION 1.4 8.1 6.7 10.7 5.6

100 5 3 5 2WHITE DISCHARGE 1.3 12.5

100 7




PD/PC

CA

TE

GO

RY

FL

UC

OR

T C

C

RE

AM

MO

MS

TA

R T

OIN

T

PR

OP

YZ

OL

E O

INT

KA

NS

EL

-B G

EL

TR

IBE

N-B

LO

TIO

N

CO

NZ

OL

E-M

L

OT

ION

ST

AT

UM

-B C

RE

AM

MO

MO

Z-T

CR

EA

M

CL

OP

-M C

RE

AM

LU

PID

ER

M-M

C

RE

AM

ZIN

CO

DE

RM

-M

CR

EA

M

BE

TN

OV

AT

E-M

S

KIN

CR

EA

M

CL

OC

IP-B

CR

EA

M

FU

NG

ID N

.C. O

INT

FL

UC

OR

T M

Z O

INT

Rx TOTAL : 44 37 37 32 30 30 28 27 25 24 23 22 21 18 17SOFT ABDOMEN 1.1 8.7

100 4SKIN INFECTION 0.9 5.4 9.1 4.8

100 5 5 3BURNING SENSATION ALL BODY0.8 8.0 17.4

100 6 11ALLERGY 0.7 9.5

100 7DANDRUFF 0.6

100SWELLING 0.6

100ALOPECIA 0.5 3.3

100 5VOMITING 0.5

100TENDERNESS 0.5 4.0

100 5INSECT BITE 0.3

100WHITE PATCH 0.3

100REDNESS OF EYE 0.3

100



TOPICAL STEROID C ANTIFUNGALSRx RS BY MAJOR PD / PC [ 1 ] Specialist :: DERMAT

PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15TINEA CRUS / CRURIS 10.8 4.0 15.1 22.6 5.0 10.0 14.7 2.9 7.7 3.8 8.0 4.5 22.7 27.8 6.7

100 6 19 14 2 5 6 1 2 1 2 1 6 6 1TINEA CORPORIS 8.7 4.0 6.6 22.6 7.5 15.0 20.6 2.9 15.4 8.0 4.5 13.6 33.3

100 7 10 18 4 9 10 2 6 3 2 4 9T V (TINEA VERSICULOSIS) 2.2 3.2 2.8 5.0 2.5 8.8 5.6

100 24 18 12 6 18 6TINEA INFECTION 1.5 1.6 2.8 2.5 2.9 3.8 8.0 9.1

100 17 25 8 8 8 17 17TINEA PEDIS 1.4 0.9 3.8 5.0 2.5 3.8

100 9 18 18 9 9TINEA MANUM 0.4 3.8

100 33DERMATITIS 6.8 6.3 4.7 9.4 3.8 2.5 15.0 11.8 5.9 7.7 15.4 16.0 4.5 9.1

100 15 9 9 4 2 11 8 4 4 8 8 2 4




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15DERMAT (CONTACT) 1.4 1.9 1.9 5.0

100 18 9 18ATOPIC DERMATITIS 0.9 0.8 2.5

100 14 14PHOTODERMATITIS 0.4 0.8

100 33SEBORRHOEA DERMATITIS 8.2 19.8 3.8 5.7 11.5 5.0 7.5 8.8 14.7 12.0 4.5 13.3

100 39 6 5 9 3 5 5 8 5 2 3PITYRIASIS 5.4 11.1 5.7 5.8 10.0 10.0 2.9 5.9 4.0

100 33 14 7 10 10 2 5 2ACNE VULGARIS / COMEDOMES5.1 6.3 12.3 1.9 5.8 2.5 8.8 11.8 3.8 4.0

100 20 33 3 8 3 8 10 3 3ECZEMA 4.6 4.0 2.8 5.7 3.8 2.5 2.5 2.9 2.9 3.8 18.2 4.5

100 14 8 8 6 3 3 3 3 3 11 3




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15P L E/P M L E(POLYMORP.LIGHT ERUP)(DERM)2.2 4.0 1.9 1.9 10.0 2.9

100 29 12 6 24 6LICHEN SIMPLEX 2.1 3.2 1.9 3.8 3.8 4.0 4.5

100 25 13 13 6 6 6PSORIASIS 1.9 1.6 1.9 1.9 2.5 3.8 3.8 4.5 6.7

100 13 7 7 7 7 7 7 7CANDIDIASIS 1.7 0.8 1.9 1.9 2.5 2.9 9.1 5.6

100 8 15 8 8 8 15 8VITILIGO 1.5 1.6 4.0

100 17 8BALANITIS 1.4 1.6 0.9 1.9 1.9 2.9

100 18 9 9 9 9HYPOPIGMENTER 1.4 3.2 1.9 1.9 5.0 2.9 4.5

100 36 9 9 18 9 9




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15RASH 1.0 2.4 1.9 3.8

100 38 13 13URTICARIA 0.8 0.9 1.9 2.5 3.8 4.0

100 17 17 17 17 17PRURITUS 0.8 1.9 3.8

100 33 17FUNGAL INFECTION 0.8 0.8 2.5 7.7 4.5

100 17 17 33 17ONYCHOMYCOSIS 0.8 0.9 2.9 6.7

100 17 17 17DERMATOPHYTOSIS 0.8 0.9 1.9

100 17 17SCABIES 0.6 0.8 0.9 3.8

100 20 20 20




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15MELASMA 0.6 0.8 1.9

100 20 40HYPERPIGMENTER 0.5 4.5

100 25IMPETIGO 0.5 0.9

100 25LESION 0.4

100ACNE VULGARIS GR II 0.4 2.5 4.0

100 33 33ERYTHEMA 0.4

100




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

CA

NE

ST

EN

-S

CR

EA

M

CA

ND

ID-B

LO

TIO

N

TE

NO

VA

TE

-M

CR

EA

M

SE

BIF

IN P

LU

S

CR

EA

M

KE

TO

-B C

RE

AM

KA

NS

EL

-B L

OT

ION

PR

OP

YZ

OL

E O

INT

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

MO

MO

Z-T

CR

EA

M

KA

NS

EL

-B G

EL

MO

MS

TA

R T

OIN

T

TR

IBE

N-B

CR

EA

M

TR

IBE

N-B

LO

TIO

N

Rx TOTAL : 126 106 53 52 40 40 34 34 26 26 25 22 22 18 15ITCHING ALL OVER BODY 3.2 1.6 1.9 3.8 3.8 2.9 5.9 7.7 4.5 9.1

100 8 8 8 8 4 8 8 4 8DANDRUFF 2.9 1.6 21.2 17.6

100 9 48 26ALOPECIA 1.4 0.8 1.9 5.8 2.5 5.9 6.7

100 9 18 27 9 18 9SKIN INFECTION 0.9 0.8 1.9 1.9 2.9 2.9

100 14 14 14 14 14INFECTION 0.9 1.9 2.9 3.8

100 14 14 14BOIL ALL OVER BODY 0.4 0.8

100 33VITAMIN DEFICIENCY 0.8 0.8 1.9 2.5 3.8

100 17 17 17 17ALLERGY 0.4 0.8

100 33



TOPICAL STEROID C ANTIFUNGALSRx RS BY MAJOR PD / PC [ 1 ] Specialist :: GYNAE

PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

CL

OT

RIN

-B

CR

EA

M

TR

IBE

N-B

CR

EA

M

ZO

LE

F O

INT

BE

TN

OV

AT

E-C

C

RE

AM

EU

MO

SO

NE

-M

CR

EA

M

SU

RF

AZ

B C

RE

AM

/ O

INT

ZO

LE

F L

OT

ION

FL

UC

OR

T C

C

RE

AM

VIN

DID

-B C

RE

AM

FU

NG

ID N

.C. O

INT

CA

ND

ID-B

LO

TIO

N

EX

FU

NG

CR

EA

M

Rx TOTAL : 65 12 12 8 7 7 4 4 4 2 2 2 2 2 2VAGINITIS 14.5 13.8 16.7 8.3 12.5 14.3 50.0 100.0

100 43 10 5 5 5 5 10PREGNANCY 13.1 16.9 8.3 16.7 50.0

100 58 5 11 5U T I (URINARY TRACT INFECTION)10.3 12.3 16.7 14.3 14.3 25.0 50.0

100 53 13 7 7 7 7PRURITUS 7.6 10.8 16.7

100 64 18FUNGAL INFECTION 5.5 7.7 14.3 50.0

100 63 13 13LEUKORRHEA 3.4 4.6

100 60AMENORRHEA 2.8 4.6

100 75




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

CL

OT

RIN

-B

CR

EA

M

TR

IBE

N-B

CR

EA

M

ZO

LE

F O

INT

BE

TN

OV

AT

E-C

C

RE

AM

EU

MO

SO

NE

-M

CR

EA

M

SU

RF

AZ

B C

RE

AM

/ O

INT

ZO

LE

F L

OT

ION

FL

UC

OR

T C

C

RE

AM

VIN

DID

-B C

RE

AM

FU

NG

ID N

.C. O

INT

CA

ND

ID-B

LO

TIO

N

EX

FU

NG

CR

EA

M

Rx TOTAL : 65 12 12 8 7 7 4 4 4 2 2 2 2 2 2CANDIDIASIS 2.1 1.5 8.3

100 33 33TINEA INFECTION 2.1 1.5 25.0

100 33 33L S C S (LOWER SEGMENT CAESARIAN SECTION2.1 1.5 8.3

100 33 33MENSTRUAL DISORDER 2.1 1.5 8.3

100 33 33RASH 1.4 1.5

100 50DERMATITIS 1.4 1.5

100 50P I D (PELVIC INFLAMATORY DISEASE) 0.7 1.5

100 100




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

CL

OT

RIN

-B

CR

EA

M

TR

IBE

N-B

CR

EA

M

ZO

LE

F O

INT

BE

TN

OV

AT

E-C

C

RE

AM

EU

MO

SO

NE

-M

CR

EA

M

SU

RF

AZ

B C

RE

AM

/ O

INT

ZO

LE

F L

OT

ION

FL

UC

OR

T C

C

RE

AM

VIN

DID

-B C

RE

AM

FU

NG

ID N

.C. O

INT

CA

ND

ID-B

LO

TIO

N

EX

FU

NG

CR

EA

M

Rx TOTAL : 65 12 12 8 7 7 4 4 4 2 2 2 2 2 2POLYP 0.7 1.5

100 100P N C (POST NATAL CARE) 0.7 1.5

100 100NAUSEA 0.7 1.5

100 100ITCHING ALL OVER BODY 21.4 27.7 8.3 41.7 28.6 14.3 50.0 50.0

100 58 3 16 7 3 7 3PAIN 4.1 4.6 8.3

100 50 17G WEAK WITH ANAEMIA 4.1 7.7 8.3 50.0

100 83 17 17PAIN ABDOMEN 3.4 3.1 8.3 14.3

100 40 20 20




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

CL

OT

RIN

-B

CR

EA

M

TR

IBE

N-B

CR

EA

M

ZO

LE

F O

INT

BE

TN

OV

AT

E-C

C

RE

AM

EU

MO

SO

NE

-M

CR

EA

M

SU

RF

AZ

B C

RE

AM

/ O

INT

ZO

LE

F L

OT

ION

FL

UC

OR

T C

C

RE

AM

VIN

DID

-B C

RE

AM

FU

NG

ID N

.C. O

INT

CA

ND

ID-B

LO

TIO

N

EX

FU

NG

CR

EA

M

Rx TOTAL : 65 12 12 8 7 7 4 4 4 2 2 2 2 2 2WHITE DISCHARGE 2.8 3.1

100 50BOIL 1.4 1.5

100 50BURNING SENSATION 2.1 3.1

100 67ABORTION 1.4 3.1

100 100BLEEDING P V 1.4 1.5

100 50SPOTTING P V 0.7 1.5

100 100



TOPICAL STEROID C ANTIFUNGALSRx RS BY MAJOR PD / PC [ 1 ] Specialist :: PAEDIA

PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

CA

ND

ID-B

L

OT

ION

CA

NE

ST

EN

-S

CR

EA

M

ZO

LE

F L

OT

ION

KE

TO

-B C

RE

AM

LO

ZE

E-M

CR

EA

M

BE

TN

OV

AT

E-C

C

RE

AM

BE

TN

OV

AT

E-M

S

KIN

CR

EA

ML

OB

AT

E-M

C

RE

AM

/ S

KIN

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

Rx TOTAL : 39 21 9 6 3 2 2 2 2 1 1 1 1RASH 7.5 7.7 4.8 11.1

100 43 14 14U R T I 5.4 5.1 9.5

100 40 40DERMATITIS 4.3 5.1 4.8

100 50 25U T I 3.2 4.8 33.3

100 33 33DIARRHOEA 2.2 2.6

100 50FUNGAL INFECTION 3.2 4.8 11.1

100 33 33VAGINITIS 2.2 4.8 66.7

100 50 100




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

CA

ND

ID-B

L

OT

ION

CA

NE

ST

EN

-S

CR

EA

M

ZO

LE

F L

OT

ION

KE

TO

-B C

RE

AM

LO

ZE

E-M

CR

EA

M

BE

TN

OV

AT

E-C

C

RE

AM

BE

TN

OV

AT

E-M

S

KIN

CR

EA

ML

OB

AT

E-M

C

RE

AM

/ S

KIN

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

Rx TOTAL : 39 21 9 6 3 2 2 2 2 1 1 1 1TINEA INFECTION 2.2 11.1

100 50LEUKORRHEA 2.2 9.5

100 100SEBORRHOEA DERMATITIS 2.2 16.7

100 50HYPOPIGMENTER 2.2 2.6

100 50CANDIDIASIS 1.1 4.8

100 100WORM INFESTATION 1.1 4.8

100 100PITYRIASIS 1.1 4.8

100 100




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

CA

ND

ID-B

L

OT

ION

CA

NE

ST

EN

-S

CR

EA

M

ZO

LE

F L

OT

ION

KE

TO

-B C

RE

AM

LO

ZE

E-M

CR

EA

M

BE

TN

OV

AT

E-C

C

RE

AM

BE

TN

OV

AT

E-M

S

KIN

CR

EA

ML

OB

AT

E-M

C

RE

AM

/ S

KIN

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

Rx TOTAL : 39 21 9 6 3 2 2 2 2 1 1 1 1R T I 1.1 2.6

100 100GASTRO ENTERITIS 1.1 2.6

100 100FEVER 11.8 10.3 19.0 11.1

100 36 36 9COUGH/COLD 11.8 12.8 9.5 11.1 16.7

100 46 18 9 9ITCHING 7.5 2.6 9.5 11.1 66.7

100 14 29 14 29LOOSE MOTION 5.4 5.1 4.8

100 40 20CONSTIPATION 2.2 2.6

100 50




PD/PC

CA

TE

GO

RY

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

CA

ND

ID-B

L

OT

ION

CA

NE

ST

EN

-S

CR

EA

M

ZO

LE

F L

OT

ION

KE

TO

-B C

RE

AM

LO

ZE

E-M

CR

EA

M

BE

TN

OV

AT

E-C

C

RE

AM

BE

TN

OV

AT

E-M

S

KIN

CR

EA

ML

OB

AT

E-M

C

RE

AM

/ S

KIN

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

TR

IBE

N-B

CR

EA

M

Rx TOTAL : 39 21 9 6 3 2 2 2 2 1 1 1 1PAIN ABDOMEN 2.2 2.6

100 50SOFT ABDOMEN 2.2 11.1

100 50G WEAK WITH ANAEMIA 2.2 2.6 4.8

100 50 50VOMITING 2.2 2.6

100 50INSECT BITE 1.1 2.6

100 100TENDERNESS 1.1 4.8

100 100



TOPICAL STEROID C ANTIFUNGALSRx RS BY MAJOR PD / PC [ 1 ] GEN PHY

PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

ZO

LE

F L

OT

ION

TR

IBE

N-B

CR

EA

M

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

CL

OT

RIN

-B C

RE

AM

SU

RF

AZ

B C

RE

AM

/ O

INT

CO

NZ

OL

E-M

L

OT

ION

FL

UC

OR

T C

C

RE

AM

Rx TOTAL : 193 85 70 59 31 30 27 17 14 14 13 12 12 11 9TINEA CRUS / CRURIS 4.2 3.1 7.1 2.9 5.1 3.3 3.7 7.1 14.3 25.0 8.3

100 21 21 7 10 3 3 3 7 10 3TINEA CORPORIS 2.6 3.1 3.5 6.5 10.0 14.3 8.3

100 33 17 11 17 11 6TINEA INFECTION 2.3 1.0 2.4 1.4 1.7 3.2 5.9 7.1 14.3

100 13 13 6 6 6 6 6 13T V (TINEA VERSICULOSIS) 1.1 6.8 7.7 8.3

100 50 13 13TINEA PEDIS 0.9 1.4 5.9 7.1 11.1

100 17 17 17 17TINEASIS 0.6 2.9 1.7 7.1

100 50 25 25TINEA CAPITIS 0.4 1.4 3.7

100 33 33




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

ZO

LE

F L

OT

ION

TR

IBE

N-B

CR

EA

M

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

CL

OT

RIN

-B C

RE

AM

SU

RF

AZ

B C

RE

AM

/ O

INT

CO

NZ

OL

E-M

L

OT

ION

FL

UC

OR

T C

C

RE

AM

Rx TOTAL : 193 85 70 59 31 30 27 17 14 14 13 12 12 11 9FUNGAL INFECTION 8.6 9.3 9.4 7.1 5.1 3.2 13.3 7.4 11.8 7.1 8.3 8.3 9.1 11.1

100 30 13 8 5 2 7 3 3 2 2 2 2 2G I DISORDER 4.9 4.1 5.9 1.4 3.4 19.4 3.7 5.9 7.1 8.3 11.1

100 24 15 3 6 18 3 3 3 3 3U T I 4.9 4.7 7.1 1.4 8.5 6.5 10.0 14.8

100 27 18 3 15 6 9 12DERMATITIS 4.4 1.0 4.7 1.7 6.5 6.7 14.8 5.9 14.3 16.7 18.2 11.1

100 7 13 3 7 7 13 3 7 7 7 3VAGINITIS 3.3 6.2 3.5 7.7 25.0 8.3

100 52 13 4 13 4PRURITUS 3.4 5.2 8.2 2.9 8.5

100 42 29 8 21RASH 3.3 4.1 3.5 1.4 9.7 11.1 7.1 9.1

100 35 13 4 13 13 4 4




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

ZO

LE

F L

OT

ION

TR

IBE

N-B

CR

EA

M

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

CL

OT

RIN

-B C

RE

AM

SU

RF

AZ

B C

RE

AM

/ O

INT

CO

NZ

OL

E-M

L

OT

ION

FL

UC

OR

T C

C

RE

AM

Rx TOTAL : 193 85 70 59 31 30 27 17 14 14 13 12 12 11 9ECZEMA 2.3 1.0 2.4 1.7 7.4 5.9 7.1 14.3 7.7

100 13 13 6 13 6 6 13 6CANDIDIASIS 1.1 2.6 8.3

100 63 13HYPOPIGMENTER 0.7 3.2 3.3

100 20 20URTICARIA 0.6 0.5 1.2 1.4

100 25 25 25SCABIES 0.6 1.0 11.1

100 50 25ABSCESS 0.4 1.2 3.7 5.9

100 33 33 33PITYRIASIS 0.4 18.2

100 67LESION 0.4 1.4 5.9

100 33 33




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

ZO

LE

F L

OT

ION

TR

IBE

N-B

CR

EA

M

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

CL

OT

RIN

-B C

RE

AM

SU

RF

AZ

B C

RE

AM

/ O

INT

CO

NZ

OL

E-M

L

OT

ION

FL

UC

OR

T C

C

RE

AM

Rx TOTAL : 193 85 70 59 31 30 27 17 14 14 13 12 12 11 9ITCHING 10.2 10.9 14.1 8.6 12.9 6.7 14.8 14.3 14.3 8.3 16.7 18.2

100 30 17 9 6 3 6 3 3 1 3 3PAIN 4.9 3.6 4.7 2.9 1.7 3.3 11.1 17.6 7.1 7.7 25.0

100 21 12 6 3 3 9 9 3 3 9FEVER 3.4 4.1 1.2 5.7 1.7 3.2 3.3 7.4 5.9 8.3

100 33 4 17 4 4 4 8 4 4G WEAK WITH ANAEMIA 3.3 4.1 4.7 1.4 3.4 3.2 3.3 7.1 7.7

100 35 17 4 9 4 4 4 4INFECTION 2.4 2.1 1.2 4.3 3.3 16.7 9.1

100 24 6 18 6 12 6BOIL ALL OVER BODY 1.9 1.6 2.4 2.9 1.7 3.7 5.9 7.1

100 23 15 15 8 8 8 8WHITE DISCHARGE 1.7 2.6 2.4 4.3

100 42 17 25




PD/PC

CA

TE

GO

RY

CA

ND

ID-B

CR

EA

M

ZO

LE

F O

INT

KE

TO

-B C

RE

AM

CA

NE

ST

EN

-S

CR

EA

M

EU

MO

SO

NE

-M

CR

EA

M

CA

ND

ID-B

LO

TIO

N

BE

TN

OV

AT

E-C

C

RE

AM

TE

NO

VA

TE

-M

CR

EA

M

ZO

LE

F L

OT

ION

TR

IBE

N-B

CR

EA

M

LO

BA

TE

-M C

RE

AM

/ S

KIN

CR

EA

M

CL

OT

RIN

-B C

RE

AM

SU

RF

AZ

B C

RE

AM

/ O

INT

CO

NZ

OL

E-M

L

OT

ION

FL

UC

OR

T C

C

RE

AM

Rx TOTAL : 193 85 70 59 31 30 27 17 14 14 13 12 12 11 9ALLERGY 1.3 1.0 2.9 7.4 5.9 7.7

100 22 22 22 11 11BURNING SENSATION 1.1 1.0 1.2 1.4 7.7

100 25 13 13 13SKIN INFECTION 1.0 1.2 1.4 11.8 8.3

100 14 14 29 14WHITE PATCH 0.6 3.2 7.4

100 25 50ALOPECIA 0.4 0.5 1.2 3.3

100 33 33 33INSECT BITE 0.4 1.4 3.2 3.3

100 33 33 33



TOP.ST.COMB.WITH ANTIFUNGALCO-RX ANALYSIS (% ) COMPOSITION

TOP.ST.COMB.WITH ANTIFUNGAL CPR DERMAT GYNAE PAEDIA GEN PHYUROLOGIS

T

RX TOTAL : 4218 780 145 93 82 63FLUCONAZOLE (S) 25.6 28.1 32.4 5.4 28 15.9TERBINAFINE (S) 4.3 10.1 0 1.1 4.9CLOTRIMAZOLE (ANTIFUNGAL) 3.8 8.1 4.1 3.2 2.4EMOLLIENTS & PROTECTIVE PREPS. 2.6 7.9 1.4 2.2 1.2GRISEOFULVIN (S) 2 3.6 0.7 1.1 2.4LEVO CETIRIZINE (S) 11.9 24.2 9 4.3 8.5CETIRIZINE (S) 8 6.8 8.3 2.2 11 3.2FEXOFENADINE (S) 3.3 2.6 1.4 1.1 3.7HYDROXYZINE (S) 3 6.4 0 0 2.4LORATADINE (S) 1.1 3.2 0 0 1.2AZITHROMYCIN PLAIN SOLIDS 3.1 4.4 3.4 1.1 3.7DOXYCYCL.HYDROCHLORIDE/ HYCLATE 1.8 1.2 2.1 0 2.4 12.7CEFIXIME (S) 1.5 0.4 2.1 1.1 2.4LEVOFLOXACIN (S) 1.4 1.2 2.1 1.1 1.2OFLOXACIN PLAIN (S) 1.4 0.1 3.4 1.2 3.2MULTIVITAMIN+MULTIMINERALS (S) 1.9 1.9 2.1 1.1 1.2VIT B-COMPLEX (S) 1.8 0.9 2.8 2.4 3.2ANTIOXIDANT VITAMINS 1.6 2.3 0.7 1.2 3.2B-COMPLEX + ZINC (S) 1.6 1.9 1.4 1.1 1.2VIT B COMPLEX ORAL LIQ 1.6 1 0.7 6.5 1.2ALBENDAZOLE (S) 2.5 1.7 3.4 1.1 3.7ORNIDAZOLE + OFLOXACIN (S) 1.8 3.4 0 2.4 12.7RABEPRAZOLE + DOMPERIDONE (CB) 1.6 0.7 2.4 20.6RABEPRAZOLE (PPI) 1.5 0.3 1.4 0 2.4PANTOPRAZOLE (PPI) 1.3 0.1 1.4 1.1 1.2ALONE 5.6 3.1 4.1 6.5 7.3 15.9DERMATOLOGICALS 47.5 78.8 42.1 22.6 43.9 20.6ANTIALLERGICS 31.4 47.7 21.4 19.4 30.5 3.2ANTIBIOTICS 24 13.6 23.4 28 28 33.3NUTRITIONALS 21.7 20 24.1 25.8 19.5 6.3G.I. 21.1 7.6 24.8 28 23.2 23.8

Date post:	31-Mar-2015
Category:	Documents
Upload:	nitish-vats
View:	403 times
Download:	1 times

24l~Topical Steroids c Anti Fungal

Documents